Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use, By Region – Market Forecast, 2025–2034

The hemostasis valve market size is expected to reach USD 339.88 million by 2034, according to a new study by Polaris Market Research. The report “Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use, By Region– Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites. It typically features a sealing mechanism that maintains hemostasis when guidewires, catheters, or other devices are introduced or withdrawn.

Global investments in healthcare infrastructure, especially in emerging markets, are expanding access to advanced interventional procedures. Governments and private organizations are increasing spending on hospitals, cath labs, and diagnostic centers equipped with modern equipment. The need for reliable tools such as hemostasis valves grows with better access to facilities capable of performing high-volume catheter-based procedures. Moreover, training programs and workshops in developing regions are raising awareness and adoption of advanced interventional practices. This growth in healthcare infrastructure creates a broader base of end users for hemostasis valves, driving steady market expansion.

Many manufacturers offer hemostasis valves as part of complete interventional procedure packs, which include syringes, introducers, and other sterile tools required for catheterization. These ready-to-use kits simplify logistics, reduce preparation time, and enhance workflow efficiency in busy clinical environments. By bundling valves into procedure packs, healthcare providers can standardize care, reduce costs, and improve safety through consistent equipment usage. This integrated approach appeals to hospitals and clinics seeking streamlined solutions, boosting overall sales of hemostasis valves and supporting long-term market growth through convenience and compatibility.

Hemostasis Valve Market Report Highlights

In 2024, the hospital segment dominated with the largest share due to their role as primary centers for complex interventional procedures.

The angioplasty segment is expected to experience significant growth during the forecast period due to its rising global use in treating blocked or narrowed arteries.

In 2024, the North America hemostasis valve market dominated with the largest share, driven by a high volume of cardiovascular procedures, advanced healthcare infrastructure, and strong adoption of minimally invasive technologies.

The Asia Pacific hemostasis valve market is experiencing significant growth due to increasing healthcare investments, rising cardiovascular disease cases, and expanding access to minimally invasive procedures.

A few global key market players are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Beijing Demax Medical Technology Co.; Boston Scientific Corporation; DeRoyal Industries, Inc.; Freudenberg Medical; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.

Polaris Market Research has segmented the hemostasis valve market report on the basis of type, application, end use, and region:

By Type (Revenue – USD Million, 2020–2034)

Hemostasis Valve Y- Connectors

Double Y- Connector Hemostasis Valves

One- Handed Hemostasis Valves

Others

By Application (Revenue – USD Million, 2020–2034)

Angiography

Angioplasty

By End Use (Revenue – USD Million, 2020–2034)

Hospitals

Ambulatory Surgical Centers

Others

By Regional Outlook (Revenue – USD Million, 2020–2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa Show more